Interleukin 13 Receptor, alpha 2 (IL13RA2) Kits ELISA

The protein encoded by IL13RA2 is closely related to Il13RA1, a subuint of the interleukin 13 receptor complex. De plus, nous expédions IL13RA2 Anticorps (122) et IL13RA2 Protéines (30) et beaucoup plus de produits pour cette protéine.

list all ELISA KIts Gène GeneID UniProt
IL13RA2 3598 Q14627
IL13RA2 16165 O88786
IL13RA2 171060  
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne

Top IL13RA2 Kits ELISA sur

Showing 4 out of 34 products:

Catalogue No. Reactivité Sensibilité Gamme Images Quantité Livraison Prix Détails
Souris 0.126 ng/mL 0.31 ng/mL - 20 ng/mL 96 Tests 13 to 16 Days
Humain 0.4 ng/mL 0.41-100 ng/mL 96 Tests 3 to 4 Days
Rat 0.078 ng/mL 0.312-20 ng/mL   96 Tests 15 to 18 Days
Chien 0.08 ng/mL n/a   96 Tests 15 to 18 Days

Plus Kits ELISA pour IL13RA2 partenaires d'interaction

Human Interleukin 13 Receptor, alpha 2 (IL13RA2) interaction partners

  1. IL-13/IL-13Ralpha2 axis can mediate signal transduction in situ via AP-1 pathway in Glioblastoma multiforme.

  2. the findings suggest that IL13Ralpha2 identifies tissue-resident intrahepatic T cells with innate characteristics and the capacity to produce IL-22.

  3. this study shows that tricellulin is regulated via interleukin-13-receptor alpha2, affects macromolecule uptake, and is decreased in ulcerative colitis

  4. IL-13Ralpha2 alone induces invasiveness of human glioblastoma multiforme (GBM) cells without affecting their proliferation. In contrast, in the presence of the mutant EGFR (EGFRvIII), IL-13Ralpha2 promotes GBM cell proliferation in vitro and in vivo.

  5. The results showed that IL13Ralpha2 may be used as a marker of poorer prognosis in high-grade astrocytomas, even among tumors of the same grade.

  6. TMEM219 plays a critical role in Chi3l1-induced IL-13Ralpha2 mediated signalling and tissue responses.

  7. This study shows interleukin-13 receptor alpha 2 expression could be a useful prognostic marker for selecting patients with luminal breast cancer likely to follow a clinically aggressive course despite receiving systemic therapy.

  8. Transgenic expression of IL15 is an appealing strategy to enhance CAR T-cell effector function. We tested this approach in our IL13Ralpha2-positive glioma model in which limited IL13Ralpha2-CAR T-cell persistence results in recurrence of antigen-positive gliomas. T cells were genetically modified with retroviral vectors encoding IL13Ralpha2-CARs or IL15 (IL13Ralpha2-CAR.IL15 T cells).

  9. IL-13Ralpha2 may have a role in decreased overall survival in gastric cancer after gastrectomy

  10. cigarette smoke extracts activate the PKA, CREB, and IL-13Ralpha2 axis in lung endothelial cells.

  11. High expression of IL-13Ra2 is significantly associated with the growth and metastasis of glioma cells via the Scr/PI3K/Akt/mTOR pathway.

  12. A negative correlation between IL-13Ra2 and IL-13 was found during early infection of human schistosomiasis, suggesting an increase in cytokine in early fibrosis.

  13. Data indicate single-chain antibody (scFv47) as a highly selective interleukin 13 receptor subunit alpha 2 (IL13Ralpha2) targeting agent.

  14. IL13Ralpha2 knockdown and IL-13 treatment cooperatively upregulated the metastasis suppressor tumor protein 63 (TP63) in a STAT6-dependent manner.

  15. Expression of CXCR3 in fibroblasts is associated with the expression of IL-13Ralpha2.

  16. In this review, we will discuss the recent advances in the IL13Ralpha2-targeted immunotherapy and evaluate the most promising strategy for targeted GBM immunotherapy. [review]

  17. Study presents evidence that PNR could promote ERalpha-negative breast cancer metastasis through activation of IL-13Ralpha2-mediated signaling pathway.

  18. Results suggest that the physical interaction between the cytoplasmic domains of IL-13Ralpha2 and IL-4Ralpha regulates IL-4 signaling through the IL-4Ralpha-IL-13Ralpha1 receptor complex.

  19. In cytotoxicity assays, CAR T cells killed CAR T cells killed IL13Ra1- and/or IL13Ra2-positive cells in contrast to IL13Ra1- and IL13Ra2-negative controls

  20. IL13Ralpha2 over-expression is associated with glioma.

Mouse (Murine) Interleukin 13 Receptor, alpha 2 (IL13RA2) interaction partners

  1. Upon lipopolysaccharide stimulation, macrophage Raw 264.7 cells showed elevated IL-13R-alpha-2 expression via immunofluorescence staining and increased MRI probe binding via built-in TAMRA fluorescence imaging. for the first time, IL-13R-alpha-2 was investigated as a unique biomarker in the context of osteomyelitis.

  2. Study presents evidence that PNR could promote ERalpha-negative breast cancer metastasis through activation of IL-13Ralpha2-mediated signaling pathway.

  3. overexpression of IL-13Ra2 inhibits the IL-13 induction of fibrotic markers in vitro and inhibits bleomycin-induced pulmonary fibrosis.

  4. data collectively support a distinct role for membrane IL-13Ralpha2 in the lung and suggest that memIL-13Ralpha2 might contribute to allergic inflammation

  5. IL-13 contributes to the development of pulmonary hypertension via an IL-13receptor alpha2-arginase 2-dependent pathway.

  6. When combined with IL-13Ralpha2 DNA cancer vaccine, Pseudomonas aeruginosa exotoxin A mediates synergistic antitumor effects on tumor growth and metastasis in established murine breast carcinoma and sarcoma tumor models.

  7. Colitis and intestinal inflammation in IL10(-/-) mice results from IL-13Ralpha2-mediated attenuation of IL-13 activity.

  8. IL-13Ralpha2 serves a protective role in the pathogenesis of allergic inflammation and loss of skin barrier function in a mouse model of atopic dermatitis.

  9. peaks of upregulation in allergic bronchial asthma at 6 hours and 3-12 hours after the last antigen inhalation

  10. studies illustrate the central role played by the IL-13Ralpha2 in the down-regulation of a chronic and pathogenic Th2-mediated immune response

  11. These results are consistent with a phenotype of enhanced interleukin-13 (IL-13)responsiveness and demonstrate a role for endogenous IL-13 and IL-13 alpha2 receptor in regulating immune responses in wild-type mice.

  12. IL-13 receptor alpha2

  13. by suppressing IFN-gamma and up-regulating the decoy IL-13 receptor, P-selectin dramatically inhibits the pathologic tissue remodeling that results from chronic type 2 cytokine-mediated hepatic inflammation

  14. TGF-beta1 production and fibrosis require IL-13 signaling through the IL-13alpha2 receptor

  15. IL-10 and IL-13Ralpha2 are both required to control chronic Th2-driven pathological responses.

  16. sIL-4Ralpha predominantly sustains, increases, and diffuses the effects of IL-4, whereas sIL-13Ralpha2 limits the direct effects of IL-13 to the site of IL-13 production and forms a stable complex with IL-13

  17. IL-13Ralpha2 is a selective and powerful inhibitor of IL-13-induced inflammatory, remodeling, and physiologic responses in the murine lung.

  18. Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2.

  19. study concludes that matrix metalloproteinase-8 cleaves IL-13R alpha 2 in vitro and contributes to the solubilization of IL-13R alpha 2 in vivo

  20. Human and murine neuroendocrine pheochromocytoma overexpress the IL-13Ralpha2 chain, and an IL-13PE-based receptor-directed anticancer approach may prove useful in treatment for metastatic pheochromocytoma patients.

IL13RA2 profil antigène

Antigen Summary

The protein encoded by this gene is closely related to Il13RA1, a subuint of the interleukin 13 receptor complex. This protein binds IL13 with high affinity, but lacks cytoplasmic domain, and does not appear to function as a signal mediator. It is reported to play a role in the internalization of IL13.

Gene names and symbols associated with IL13RA2

  • interleukin 13 receptor, alpha 2 (il13ra2) anticorps
  • interleukin 13 receptor subunit alpha 2 (IL13RA2) anticorps
  • interleukin 13 receptor subunit alpha 2 S homeolog (il13ra2.S) anticorps
  • interleukin 13 receptor, alpha 2 (Il13ra2) anticorps
  • interleukin 13 receptor subunit alpha 2 (Il13ra2) anticorps
  • CD213a2 anticorps
  • CT19 anticorps
  • IL-13R anticorps
  • IL-13R-alpha-2 anticorps
  • il-13ra2 anticorps
  • IL13BP anticorps
  • IL13RA2 anticorps
  • sb:cb602 anticorps
  • si:dkeyp-110c7.6 anticorps

Protein level used designations for IL13RA2

interleukin-13 receptor alpha 2 , interleukin-13 receptor subunit alpha-2 , IL-13 receptor alpha 2 , interleukin 13 receptor, alpha 2 , interleukin-13 receptor subunit alpha-2-like , IL-13 receptor subunit alpha-2 , IL-13R subunit alpha-2 , IL-13R-alpha-2 , IL-13RA2 , cancer/testis antigen 19 , interleukin 13 binding protein , interleukin 13 receptor alpha 2 chain , interleukin-13-binding protein , interleukin 13 receptor alpha chain 2

368326 Danio rerio
422219 Gallus gallus
465815 Pan troglodytes
495398 Xenopus laevis
100441311 Pongo abelii
100601369 Nomascus leucogenys
3598 Homo sapiens
403622 Canis lupus familiaris
16165 Mus musculus
171060 Rattus norvegicus
616008 Bos taurus
Fournisseurs de qualité sélectionnés pour IL13RA2 (IL13RA2) Kits ELISA
Avez-vous cherché autre chose?